SCHEMBL6454014

SCHEMBL6454014

O=C(O)N1CCC(N(C(=O)c2ccc3ccccc3c2)C2CCCC2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 5/20 0.65
SLC6A2 P23975 3/20 0.63
SLC6A3 Q01959 2/20 0.63
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
DRD4 P21917 3/20 0.45
LMNA P02545 3/20 0.44
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CHRM4 P08173 1/20 0.44
TSHR P16473 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43
RECQL P46063 1/20 0.43
ADAM17 P78536 1/20 0.43
KMT2A Q03164 1/20 0.43
KCNH2 Q12809 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6411523 0.99 SLC6A4 (0.67) SLC6A4SLC6A2SLC6A3NPC1RAB9A
SCHEMBL31026371 0.87 SLC6A4 (0.79) SLC6A4SLC6A2SLC6A3LMNAMAPT
SCHEMBL6449429 0.82 SLC6A4 (0.48) SLC6A4SLC6A2SLC6A3NPC1RAB9A
SCHEMBL2230656 0.81 SLC6A4 (0.68) SLC6A4SLC6A2SLC6A3NPC1RAB9A
SCHEMBL6414261 0.81 SLC6A4 (0.97) SLC6A4SLC6A2SLC6A3LMNAKDM4E
SCHEMBL2230652 0.78 SLC6A4 (0.62) SLC6A4SLC6A2SLC6A3LMNAMAPT
SCHEMBL29539649 0.78 SLC6A4 (0.62) SLC6A4SLC6A2SLC6A3LMNAMAPT
SCHEMBL6439473 0.77 SLC6A4 (0.53) SLC6A4SLC6A2SLC6A3NPC1RAB9A
SCHEMBL6410755 0.76 KDM2B (0.43) SLC6A4SLC6A2SLC6A3LMNAMAPT
SCHEMBL34931 0.74 SLC6A4 (0.60) SLC6A4SLC6A2SLC6A3NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014789-A1 Amide derivatives as selective serotonin re-uptake inhibitors PFIZER INC 2005-01-20 US disclosed
WO-2004111003-A1 AMIDE DERIVATIVES AS SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS PFIZER LIMITED (GB) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014789-A1 Amide derivatives as selective serotonin re-uptake inhibitors SLC6A4, HTR3C, HTR3A SLC6A4 1/4885SLC6A2 7/4885SLC6A3 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.